Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Baylin

Showing results (31-40 of 235) with videos related to

Pageof 24
Sort By:
Nature Reviews. Cancer|September 24, 2011
A decade of exploring the cancer epigenome - biological and translational implicationsStephen B Baylin, Peter A Jones
The Journal of Clinical Investigation|January 3, 2014
Harnessing the potential of epigenetic therapy to target solid tumorsNita Ahuja, Hariharan Easwaran, Stephen B Baylin
Oncoscience|February 26, 2019
DNA methylation in senescence, aging and cancerWenbing Xie, Stephen B Baylin, Hariharan Easwaran
Nature Genetics|June 29, 2006
CIMPle origin for promoter hypermethylation in colorectal cancer?Kornel Schuebel, Wei Chen, Stephen B Baylin
Annual Review of Medicine|January 16, 2016
Epigenetic Therapeutics: A New Weapon in the War Against CancerNita Ahuja, Anup R Sharma, Stephen B Baylin
Molecular Cell|June 7, 2014
Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistanceHariharan Easwaran, Hsing-Chen Tsai, Stephen B Baylin
Blood Reviews|January 24, 2006
The fundamental role of epigenetics in hematopoietic malignanciesOliver Galm, James G Herman, Stephen B Baylin
Cell Cycle (Georgetown, Tex.)|May 8, 2003
Hedgehog signaling: progenitor phenotype in small-cell lung cancerD Neil Watkins, David M Berman, Stephen B Baylin
Current Opinion in Genetics & Development|December 3, 2014
Cancer-like epigenetic derangements of human pluripotent stem cells and their impact on applications in regeneration and repairJeffrey S Huo, Stephen B Baylin, Elias T Zambidis
Plos Genetics|August 16, 2008
Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG islandHeather M O'Hagan, Helai P Mohammad, Stephen B Baylin
Pageof 24

Showing results (31-40 of 235) with videos related to

Sort By:
Pageof 24
Nature Reviews. Cancer|September 24, 2011
A decade of exploring the cancer epigenome - biological and translational implicationsStephen B Baylin, Peter A Jones
The Journal of Clinical Investigation|January 3, 2014
Harnessing the potential of epigenetic therapy to target solid tumorsNita Ahuja, Hariharan Easwaran, Stephen B Baylin
Oncoscience|February 26, 2019
DNA methylation in senescence, aging and cancerWenbing Xie, Stephen B Baylin, Hariharan Easwaran
Nature Genetics|June 29, 2006
CIMPle origin for promoter hypermethylation in colorectal cancer?Kornel Schuebel, Wei Chen, Stephen B Baylin
Annual Review of Medicine|January 16, 2016
Epigenetic Therapeutics: A New Weapon in the War Against CancerNita Ahuja, Anup R Sharma, Stephen B Baylin
Molecular Cell|June 7, 2014
Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistanceHariharan Easwaran, Hsing-Chen Tsai, Stephen B Baylin
Blood Reviews|January 24, 2006
The fundamental role of epigenetics in hematopoietic malignanciesOliver Galm, James G Herman, Stephen B Baylin
Cell Cycle (Georgetown, Tex.)|May 8, 2003
Hedgehog signaling: progenitor phenotype in small-cell lung cancerD Neil Watkins, David M Berman, Stephen B Baylin
Current Opinion in Genetics & Development|December 3, 2014
Cancer-like epigenetic derangements of human pluripotent stem cells and their impact on applications in regeneration and repairJeffrey S Huo, Stephen B Baylin, Elias T Zambidis
Plos Genetics|August 16, 2008
Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG islandHeather M O'Hagan, Helai P Mohammad, Stephen B Baylin
Pageof 24